Skip to main content
Equibles

VRXA · Veraxa Biotech AG - Post de-SPAC · Financials

Track VRXA — free

Use VRXA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VRXA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.21 +0.08 (+7.08%)
Rebalance outlook locked
Market Cap
$199.39M
Shares
141.41M
Volume · Oct 5 154.08K Avg daily vol (3M) 393.01K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Operating Cash Flow
-9.9M -28.3%
FY2025 Operating Cash Flow FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
No structured figures reported for this view yet.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 2079109 CUSIP H9130A103 Visit website Investor relations